MOC.WA
Price:
$5.88
Market Cap:
$121.15M
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in Mar...[Read more]
Industry
Biotechnology
IPO Date
2018-04-01
Stock Exchange
WSE
Ticker
MOC.WA
According to Molecure S.A.’s latest financial reports and current stock price. The company's current PE Ratio is -5.94. This represents a change of -42.79% compared to the average of -10.38 of the last 4 quarters.
The mean historical PE Ratio of Molecure S.A. over the last ten years is -43.39. The current -5.94 PE Ratio has changed 1.27% with respect to the historical average. Over the past ten years (40 quarters), MOC.WA's PE Ratio was at its highest in in the December 2020 quarter at 2.65. The PE Ratio was at its lowest in in the September 2016 quarter at -1639.33.
Average
-43.39
Median
-23.46
Minimum
-140.76
Maximum
10.13
Discovering the peaks and valleys of Molecure S.A. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 31.96%
Maximum Annual PE Ratio = 10.13
Minimum Annual Increase = -477.73%
Minimum Annual PE Ratio = -140.76
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -8.61 | 31.96% |
| 2024 | -6.52 | -43.64% |
| 2023 | -11.57 | -21.69% |
| 2022 | -14.78 | -61.37% |
| 2021 | -38.25 | -477.73% |
| 2020 | 10.13 | -131.49% |
| 2019 | -32.15 | -37.87% |
| 2018 | -51.75 | -63.23% |
| 2017 | -140.76 | 0.83% |
| 2016 | -139.60 | -80.31% |
The current PE Ratio of Molecure S.A. (MOC.WA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-8.90
5-year avg
-15.94
10-year avg
-43.39
Molecure S.A.’s PE Ratio is less than Mabion S.A. (-2.05), less than Poltreg S.A. (-3.26), greater than NanoGroup S.A. (-9.91), less than Pure Biologics Spólka Akcyjna (-2.73), greater than Genomtec S.A. (-7.99), greater than Urteste S.A. (-9.12), greater than Medinice S.A. (-119.19), greater than Captor Therapeutics Spolka Akcyjna (-10.15), greater than Pharmena S.A. (-13.27), less than Airway Medix S.A. (23.40),
| Company | PE Ratio | Market cap |
|---|---|---|
| -2.05 | $117.02M | |
| -3.26 | $89.07M | |
| -9.91 | $73.82M | |
| -2.73 | $20.24M | |
| -7.99 | $75.25M | |
| -9.12 | $64.71M | |
| -119.19 | $676.45M | |
| -10.15 | $494.00M | |
| -13.27 | $36.64M | |
| 23.40 | $29.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Molecure S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Molecure S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Molecure S.A.'s PE Ratio?
How is the PE Ratio calculated for Molecure S.A. (MOC.WA)?
What is the highest PE Ratio for Molecure S.A. (MOC.WA)?
What is the 3-year average PE Ratio for Molecure S.A. (MOC.WA)?
What is the 5-year average PE Ratio for Molecure S.A. (MOC.WA)?
How does the current PE Ratio for Molecure S.A. (MOC.WA) compare to its historical average?